Page last updated: 2024-08-26

1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and Brain Vascular Disorders

1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine has been researched along with Brain Vascular Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiguchi, I; Kimura, J; Nakamura, S1

Other Studies

1 other study(ies) available for 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and Brain Vascular Disorders

ArticleYear
The histochemical demonstration of MPTP oxidation in the postmortem human striatum.
    Neuroscience letters, 1993, May-14, Volume: 154, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Caudate Nucleus; Cerebrovascular Disorders; Clorgyline; Corpus Striatum; Dopamine Agents; Female; Glial Fibrillary Acidic Protein; Histocytochemistry; Humans; Male; Monoamine Oxidase; Neuroglia; Oxidation-Reduction; Putamen; Selegiline

1993